Tus Pharmaceutical Group Co Ltd (000590) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tus Pharmaceutical Group Co Ltd (000590) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥2.24 Million ≈ $327.43K USD) by net assets (CN¥585.85 Million ≈ $85.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Tus Pharmaceutical Group Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Tus Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Tus Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Tus Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tus Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ld Intelligent Technology Co Ltd
SHE:300883
|
0.008x |
|
Unitech Computer Co Ltd
TW:2414
|
0.057x |
|
Steelcast Limited
NSE:STEELCAS
|
0.123x |
|
JTL Industries Ltd
NSE:JTLIND
|
-0.064x |
|
Rotshtein
TA:ROTS
|
-0.082x |
|
Materialise NV
NASDAQ:MTLS
|
0.027x |
|
Rossari Biotech Limited
NSE:ROSSARI
|
0.024x |
|
Shenzhen Ecobeauty Co Ltd
SHE:000010
|
0.086x |
Annual Cash Flow Conversion Efficiency for Tus Pharmaceutical Group Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Tus Pharmaceutical Group Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Tus Pharmaceutical Group Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥549.49 Million ≈ $80.41 Million |
CN¥28.96 Million ≈ $4.24 Million |
0.053x | +82.22% |
| 2024-12-31 | CN¥601.23 Million ≈ $87.98 Million |
CN¥17.39 Million ≈ $2.54 Million |
0.029x | +174.17% |
| 2023-12-31 | CN¥728.20 Million ≈ $106.56 Million |
CN¥-28.39 Million ≈ $-4.16 Million |
-0.039x | -150.29% |
| 2022-12-31 | CN¥702.49 Million ≈ $102.80 Million |
CN¥54.47 Million ≈ $7.97 Million |
0.078x | +109.99% |
| 2021-12-31 | CN¥682.32 Million ≈ $99.85 Million |
CN¥25.20 Million ≈ $3.69 Million |
0.037x | -53.74% |
| 2020-12-31 | CN¥644.88 Million ≈ $94.37 Million |
CN¥51.48 Million ≈ $7.53 Million |
0.080x | +70.04% |
| 2019-12-31 | CN¥622.16 Million ≈ $91.04 Million |
CN¥29.21 Million ≈ $4.27 Million |
0.047x | +4059.95% |
| 2018-12-31 | CN¥579.72 Million ≈ $84.83 Million |
CN¥654.24K ≈ $95.74K |
0.001x | +100.74% |
| 2017-12-31 | CN¥583.33 Million ≈ $85.36 Million |
CN¥-89.14 Million ≈ $-13.04 Million |
-0.153x | -24.06% |
| 2016-12-31 | CN¥263.96 Million ≈ $38.63 Million |
CN¥-32.51 Million ≈ $-4.76 Million |
-0.123x | +58.14% |
| 2015-12-31 | CN¥205.79 Million ≈ $30.11 Million |
CN¥-60.56 Million ≈ $-8.86 Million |
-0.294x | -6.42% |
| 2014-12-31 | CN¥184.11 Million ≈ $26.94 Million |
CN¥-50.91 Million ≈ $-7.45 Million |
-0.277x | -1907.88% |
| 2013-12-31 | CN¥269.51 Million ≈ $39.44 Million |
CN¥4.12 Million ≈ $603.20K |
0.015x | -62.93% |
| 2012-12-31 | CN¥478.58 Million ≈ $70.03 Million |
CN¥19.75 Million ≈ $2.89 Million |
0.041x | -53.10% |
| 2011-12-31 | CN¥350.83 Million ≈ $51.34 Million |
CN¥30.87 Million ≈ $4.52 Million |
0.088x | -71.13% |
| 2010-12-31 | CN¥278.88 Million ≈ $40.81 Million |
CN¥84.98 Million ≈ $12.43 Million |
0.305x | +106.35% |
| 2009-12-31 | CN¥231.22 Million ≈ $33.84 Million |
CN¥34.14 Million ≈ $5.00 Million |
0.148x | +36.63% |
| 2008-12-31 | CN¥322.78 Million ≈ $47.23 Million |
CN¥34.89 Million ≈ $5.10 Million |
0.108x | -51.20% |
| 2007-12-31 | CN¥307.22 Million ≈ $44.96 Million |
CN¥68.04 Million ≈ $9.96 Million |
0.221x | +357.48% |
| 2006-12-31 | CN¥271.26 Million ≈ $39.69 Million |
CN¥-23.33 Million ≈ $-3.41 Million |
-0.086x | -141.28% |
| 2005-12-31 | CN¥268.54 Million ≈ $39.30 Million |
CN¥55.96 Million ≈ $8.19 Million |
0.208x | +15.06% |
| 2004-12-31 | CN¥267.57 Million ≈ $39.15 Million |
CN¥48.46 Million ≈ $7.09 Million |
0.181x | +292.13% |
| 2003-12-31 | CN¥259.16 Million ≈ $37.92 Million |
CN¥-24.43 Million ≈ $-3.57 Million |
-0.094x | -128.08% |
| 2002-12-31 | CN¥280.91 Million ≈ $41.11 Million |
CN¥94.30 Million ≈ $13.80 Million |
0.336x | +283.41% |
| 2001-12-31 | CN¥278.65 Million ≈ $40.78 Million |
CN¥-51.00 Million ≈ $-7.46 Million |
-0.183x | -944.87% |
| 2000-12-31 | CN¥380.02 Million ≈ $55.61 Million |
CN¥8.23 Million ≈ $1.20 Million |
0.022x | +172.82% |
| 1999-12-31 | CN¥347.80 Million ≈ $50.89 Million |
CN¥-10.35 Million ≈ $-1.51 Million |
-0.030x | -305.60% |
| 1998-12-31 | CN¥268.78 Million ≈ $39.33 Million |
CN¥3.89 Million ≈ $569.06K |
0.014x | -- |
About Tus Pharmaceutical Group Co Ltd
Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China. It operates through the Pharmaceutical and Health Product Manufacturing and Sales Business, Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business, and Other Business segments. The company offer… Read more